Tabelecleucel Under Review for EBV Post-Transplant Lymphoproliferative Disease Treatment
Tabelecleucel, an investigational treatment, is under review for the treatment of Epstein-Barr virus (EBV) post-transplant…
Tabelecleucel, an investigational treatment, is under review for the treatment of Epstein-Barr virus (EBV) post-transplant…
A generous donation enables the MDI Biological Laboratory to create its first endowed faculty chair,…
Stanford researchers have developed a novel tool to accurately measure biological age, paving the way…
The US Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) has updated its…
The recent bankruptcy filing of 23andMe has sparked concerns over the privacy and security of…
Israeli scientists have made a groundbreaking discovery in the field of biotechnology, designing a mutant…
Biovaxys announces extension of offering closing date to facilitate ongoing discussions and negotiations.
A filmmaker has joined a biotech effort to bring back the extinct giant bird, the…
Mayo Clinic researchers have made a groundbreaking discovery using stem cells to minimize the need…